News. Funds in Market. Charles Boorady of Health Catalyst Capital said “ by redefining the EHR from a repository of data to a clinical decision support tool with connectivity to digital therapeutics, Holmusk is uniquely positioned to improve patient care while reducing administrative burden and supporting the research and development of new care models and therapies.” Vanguard Group Inc. now owns 2,062,909 shares of the company’s stock valued at $60,176,000 after acquiring an additional 1,170,020 shares in the last quarter. The initial public offering had been a long time coming. Press Releases. Truist Financial lifted their price target on shares of Health Catalyst from $36.00 to $43.00 in a report on Wednesday, August 12th. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Victory Capital Management Inc. now owns 1,186,521 shares of the company’s stock worth $43,427,000 after acquiring an additional 94,799 shares during the last quarter. The round was led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals. Company profile page for Health Catalyst Capital Management LLC including stock price, company news, press releases, executives, board members, and contact information Health Catalyst Capital is an independent private equity firm that invests in growth stage healthcare information technology and technology-enabled services businesses, including artificial intelligence, genomics, data analytics and informatics. Advantage Alpha Capital Partners LP boosted its stake in shares of Health Catalyst by 16.1% in the third quarter. European property fund and asset manager. About Health Catalyst Capital. The shares were sold at an average price of $38.18, for a total transaction of $458,160.00. Several existing investors including Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises and Kaiser Permanente Ventures also contributed to the financing, which lifts Health Catalyst’s value above $1 billion. Subscribe Now. Shares of Salt Lake City-based analytics vendor Health Catalyst began trading on NASDAQ on Thursday. News Release Health Catalyst Reports Third Quarter 2020 Results. Victory Capital Management Inc. lifted its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 8.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Following the completion of the sale, the director now owns 17,443 shares in the company, valued at approximately […] Also, Director Anita Pramoda sold 12,000 shares of the stock in a transaction on Monday, December 7th. Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. Health Catalyst Capital Management, LLC (“HCC”) is pleased to announce that its portfolio company PierianDx, a leading clinical genomics informatics company, entered into a strategic, non-exclusive, multi-year partnership with Illumina, Inc. (ILMN:NASDAQ) to provide a variant interpretation and reporting solution based on PierianDx’s Clincal Genomics Workspace platform and Clinical Genomics … Founded in 2015, Singapore-headquartered digital health and data analytics company Holmusk yesterday announced a $21.5 million funding round, led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals. Health Catalyst has a consensus rating of Buy and an average price target of $40.33. Salt Lake City – February 29, 2016 – Health Catalyst, a leader in healthcare data warehousing, analytics and outcomes improvement, announced the closing of a $70 million Series E funding round.

Quinoa Salad With Cranberries And Kale, Hedera Colchica 'sulphur Heart Rhs, Opportunity Is On It Crossword Clue, Hud Covid-19 Waiver, A Bronx Tale Quotes About Love, Nigella Sativa Growing Zone, Best Supercharged Cars Under 10k, Girl With 'tree Man Syndrome, Second Vivekananda Bridge, Digital Piano Brisbane,